These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15816856)

  • 1. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.
    Santiard-Baron D; Langui D; Delehedde M; Delatour B; Schombert B; Touchet N; Tremp G; Paul MF; Blanchard V; Sergeant N; Delacourte A; Duyckaerts C; Pradier L; Mercken L
    J Neurochem; 2005 Apr; 93(2):330-8. PubMed ID: 15816856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
    Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
    Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD.
    Nakaya T; Suzuki T
    Genes Cells; 2006 Jun; 11(6):633-45. PubMed ID: 16716194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.
    Ma QH; Futagawa T; Yang WL; Jiang XD; Zeng L; Takeda Y; Xu RX; Bagnard D; Schachner M; Furley AJ; Karagogeos D; Watanabe K; Dawe GS; Xiao ZC
    Nat Cell Biol; 2008 Mar; 10(3):283-94. PubMed ID: 18278038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
    Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL
    Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dab1 binds to Fe65 and diminishes the effect of Fe65 or LRP1 on APP processing.
    Kwon OY; Hwang K; Kim JA; Kim K; Kwon IC; Song HK; Jeon H
    J Cell Biochem; 2010 Oct; 111(2):508-19. PubMed ID: 20568118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
    Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
    J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-specific knockout of FE65 leads to impaired learning and memory.
    Wang B; Hu Q; Hearn MG; Shimizu K; Ware CB; Liggitt DH; Jin LW; Cool BH; Storm DR; Martin GM
    J Neurosci Res; 2004 Jan; 75(1):12-24. PubMed ID: 14689444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of APP in brains of transgenic mice containing the entire human APP gene.
    Buxbaum JD; Christensen JL; Ruefli AA; Greengard P; Loring JF
    Biochem Biophys Res Commun; 1993 Dec; 197(2):639-45. PubMed ID: 8267600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.